Clinical trials
Parkinson clinical trials
Below are recruiting parkinson clinical trials, each written for real people, not researchers. We’re tracking 735 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07227896Recruiting
Study of a new pump treatment for advanced Parkinson's
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
Georgetown, TexasAges 18–80 - NCT06914466Recruiting
DBS for sleep problems in Parkinson's disease
This study looks at how deep brain stimulation (DBS) affects sleep problems in people with Parkinson's disease. It aims to understand brain changes and improve sleep quality.
Beijing, Beijing MunicipalityAges 19–80 - NCT07216066RecruitingPhase 1
Study of ALN-SNCA for early Parkinson's disease
This trial tests a new experimental drug called ALN-SNCA, given as an injection into the spinal fluid, for people with early Parkinson's disease. The goal is to see if it is safe and well-tolerated.
Ottawa, OntarioAges 50–80 - NCT06916260Recruiting
Light therapy study for people with Parkinson's disease
This study tests whether light therapy can help people with Parkinson's disease. Participants will receive light therapy sessions and have their symptoms checked before, after, and three months later.
Newark, DelawareAges 50–80 - NCT07213856Recruiting
Dietary help for constipation in Parkinson's disease
This study tests whether a special diet can help improve constipation symptoms in people with early-stage Parkinson's disease. It aims to see if changing what you eat can make bowel movements more regular and comfortable.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT07221266Recruiting
Exercise programs for people with Parkinson’s
This study tests how different exercise programs affect movement, fitness, and quality of life in people with Parkinson’s disease. It may help you find an exercise routine that improves your symptoms.
El Paso, TexasAges 50 years+ - NCT07213219Recruiting
PET-MRI scan for Parkinson's with sleep behavior disorder
This trial uses a combined PET and MRI scan to study the brain's reward system in people with Parkinson's disease who also have REM sleep behavior disorder (RBD). It aims to understand how the brain changes and may help guide future treatments.
Clermont-FerrandAges 45–80 - NCT07218952Enrolling by invitation
Radiation therapy for Parkinson's disease
This trial tests if a targeted radiation therapy can help people with early-stage Parkinson's disease that affects only one side of the body. It aims to see if this treatment can slow down the disease and improve symptoms.
Rochester, MinnesotaAges 45–70 - NCT07213232Enrolling by invitation
Balance and thinking training for Parkinson's
This study tests if combining balance and walking exercises with thinking tasks can improve movement and daily life in people with Parkinson's disease. It is for those in early to moderate stages who can participate in physical and cognitive training.
Ankara, ÜniversitelerAges 40 years+ - NCT05182892Recruiting
Reducing speech side effects from DBS using speech recordings
This study tests whether automated analysis of your speech can help reduce speech problems caused by deep brain stimulation (DBS) in Parkinson’s disease. It may help your team adjust DBS settings to improve how you speak while keeping Parkinson symptoms controlled.
PragueAges 18 years+ - NCT06893055Recruiting
Strength and endurance training for Parkinson's
This study tests a circuit training program that combines strength and endurance exercises to see if it helps people with Parkinson's disease improve their movement and daily function.
Prague, PragueAges 18–75 - NCT05576818RecruitingPhase 3
Synbiotic add-on for people with Parkinson’s disease
This trial tests whether adding a synbiotic (a mix of probiotics and prebiotics) along with standard Parkinson’s medicines can improve symptoms or health outcomes. It’s mainly for adults with Parkinson’s disease at earlier to mid-stages who take dopamine replacement therapy.
Tanta, El GharbiaAges 45–65 - NCT06573762Recruiting
Home monitoring for Parkinson's disease
This study uses a Fitbit to track movement and symptoms from home. It is for people who are newly referred or recently diagnosed with Parkinson's disease.
Iowa City, IowaAges 50–110 - NCT07207122Recruiting
Focused ultrasound for Parkinson's cognitive symptoms
This trial tests whether a non-invasive ultrasound treatment, called transcranial focused ultrasound stimulation (tFUS), can improve movement and thinking in people with Parkinson's disease. It may be an option for those whose symptoms are not well controlled by medication alone.
Tucson, ArizonaAges 22–80 - NCT07207057RecruitingPhase 3
Platform trial testing multiple drugs for Parkinson's disease
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
LondonAges 30 years+ - NCT06232772Recruiting
Biomarkers for early Parkinson's diagnosis
This study looks for new markers in the blood or other samples to help diagnose Parkinson's disease earlier. It compares people with Parkinson's, related conditions (like multiple system atrophy or progressive supranuclear palsy), and healthy volunteers to find differences.
Nanning, GuangxiAges 18–80 - NCT07187739Recruiting
Mediterranean diet for Parkinson's with deep brain stimulation
This study tests whether a Mediterranean diet can improve nutrition in people with Parkinson's disease who have had deep brain stimulation surgery. It may help you maintain better nutrition and overall health.
Ankara, AnkaraAges 45–64 - NCT07190404Recruiting
Thinking skills program for Parkinson's disease
This study tests a program to help people with Parkinson's disease who are noticing problems with their memory or thinking. The program teaches strategies to manage daily thinking challenges.
St Louis, MissouriAges 50 years+ - NCT07176494Recruiting
Revision of Deep Brain Stimulator in Parkinson's Disease
This study is for people with Parkinson's disease who need to have their deep brain stimulator (a device that sends electrical pulses to control movement) replaced or adjusted. The researchers want to learn the best way to do this procedure safely.
Ankara, Yenimahalle\AnkaraAges 40–85 - NCT07176091Enrolling by invitation
Magnetic brain stimulation for Parkinson's disease pain
This trial tests a special type of magnetic brain stimulation (called TMS) to see if it can help with Parkinson's disease and the pain that often comes with it. You must have had Parkinson's for at least 3 years, have frequent pain, and be on stable medications.
Suzhou, JiangsuAges 40–80 - NCT07175922Recruiting
A study of gene changes in people with Parkinson's disease
This study looks at how the csgA gene changes over time in people with Parkinson's disease, especially if they have stomach or bowel issues. It aims to help understand how these changes might relate to symptoms.
LeidenAges 18–80 - NCT07182058RecruitingPhase 1/Phase 2
Brain stimulation device for Parkinson's motor symptoms
This trial tests a wearable brain stimulation device (tES) that delivers gentle electrical currents to your head to help improve Parkinson's motor symptoms like tremor, stiffness, or slowness. The treatment is done at home with remote video monitoring, and may offer a non-medication option to help with movement.
Cleveland, OhioAges 18–80 - NCT07166757RecruitingPhase 1/Phase 2
Study of XS411 for early-onset Parkinson's disease
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07174310RecruitingPhase 3
Prasinezumab for early Parkinson's disease
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
Birmingham, AlabamaAges 50–85
Hear when a new Parkinson trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson?
- Yes. Clin2 currently lists 735 recruiting parkinson studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.